RESULTS

Non-invasive detection of tumors by volatile organic compounds in urine (Biomedicines, 2025)

In the academia-industry collaboration, Dr. Hara’s work focuses on the early detection of cancer, a leading cause of death that becomes increasingly difficult to treat as it progresses. Current blood biomarker tests have limitations in diagnosing early-stage cancer, highlighting the need for new biomarkers and diagnostic methods. This review examines recent advancements in cancer biomarker detection, particularly the analysis of volatile organic compounds (VOCs) in urine and the use of olfactory receptors.